Vanderbilt University Medical Center: Gut Microbiota And Lung Fibrosis
February 07, 2023
February 07, 2023
NASHVILLE, Tennessee, Feb. 7 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Growing evidence supports a gut-lung axis: a connection between the gut, including its microorganisms (microbiota), and lung disease outcomes.
Wonder Drake, MD, and colleagues explored the influence of the gut microbiota on lung fibrosis using mice housed in conditions of increasing microbe exposure: germ-free, biosafety level 1 (ABSL-1), and biosafety level 2 (ABSL . . .
Growing evidence supports a gut-lung axis: a connection between the gut, including its microorganisms (microbiota), and lung disease outcomes.
Wonder Drake, MD, and colleagues explored the influence of the gut microbiota on lung fibrosis using mice housed in conditions of increasing microbe exposure: germ-free, biosafety level 1 (ABSL-1), and biosafety level 2 (ABSL . . .